Where does CytoChip Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), CytoChip Inc. ranks #15,939 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does CytoChip Inc. hold?

CytoChip Inc. holds 18 US utility patents granted between 2018 and 2025, spanning 7 technology areas.

What is CytoChip Inc.'s Innovation Score?

CytoChip Inc. has an Innovation Score of 51.0 out of 100 (top 12% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does CytoChip Inc. focus on?

CytoChip Inc.'s top technology area is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE) with 14 patents, ranking #129 of 1,325 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is CytoChip Inc.'s patent grant rate increasing or decreasing?

CytoChip Inc.'s recent grant velocity is +650% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for CytoChip Inc.'s patents?

CytoChip Inc.'s patents average 21.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the CytoChip Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

CytoChip Inc.

USPTO PatentsView assignee record - 18 granted patents across 7 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01L (Chemical OR Physical Laboratory Apparatus FOR General USE).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cytochip ranks #15,939 of 49,997 tracked US assignees by granted-patent volume, with 18 patents across 7 technology areas.

#15,939
of 49,997 US assignees by volume: Top 12%
by Innovation Score (51.0/100): 21.9
avg claims per patent: +650%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R15939 · US Corporation #15,939 · 18 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 18 grants
MID-PACK #15,939/49,997
PHOTO-FINISH Coventor
CPC-NARROW B01L · 7 areas
INNOV-PAR 51.0/100
CLAIMS-DENSE 21.9 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +650% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Coventor, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cytochip’s 51.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.2 pts (20%) Velocity 18.3 pts (36%) Breadth 9.4 pts (18%) Claim depth 13.2 pts (26%)

Qualcomm Incorporated · highest

85
CytoChip · this assignee

51
3D Lighting… · lowest

7

What this shows Cytochip's Innovation Score is 51.0/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Cytochip?

Each dot is one of Cytochip’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cytochip’s own 21.9 claims/patent is ABOVE the 10.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Cytochip vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cytochip's grants concentrate

CytoChip Inc. is a focused PatentsView assignee: 7 CPC subclasses with 77.8% of grants classified under B01L (Chemical OR Physical Laboratory Apparatus FOR General USE). Peak complete grant year is 2024 (5 grants) versus a trough of 2 in 2018. By volume, Cytochip sits between Coventor, Inc. and DBV Technologies.

Cytochip's three-year grant acceleration

CytoChip Inc. shows 11 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Coventor

18
Crossbay Medical

18
Cyclazoom

18
Cytiva US

18
Daher Aerospace

18
Daido Kogyo

18
Dakang Holding

18
DBV

18
Cytochip ◀

18

What this shows CytoChip holds 18 patents at rank #15,939, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near CytoChip

By rank, the assignees closest to #15,939 in granted patent volume.

Leaders in B01L (Chemical OR Physical Laboratory Apparatus FOR General USE)

Other assignees with the most granted patents in CytoChip's primary technology class.

Cytochip's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

CytoChip Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	2	11.1%
2020	2	11.1%
2021	2	11.1%
2022	3	16.7%
2023	3	16.7%
2024	5	27.8%
2025partial year	1	5.6%

Which technologies does CytoChip Inc. patent most?

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 14

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 11

A61B - DIAGNOSIS; SURGERY; Identification 7

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 3

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 2

B32B - Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form 2

G01F - Measuring Volume, Volume Flow, Mass Flow OR Liquid LEVEL; Metering BY Volume 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

CytoChip Inc.'s patent record in context - here's where to go next.

CytoChip Inc.'s lead technology class is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), 77.8% of its portfolio - see every assignee active in that class. Explore B01L
Ranked #15,939 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare CytoChip Inc. against Coventor, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 51.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.